Oxytocin and Autism Ranking:

Ongoing Research

• The Children's Hospital of Philadelphia is running a trial to to determine the safety and therapeutic potential of intranasal oxytocin in children and adolescents with autism spectrum disorder (ASD) when paired with a computer game intervention that is designed to enhance face perception skills. Clinical Trials Gov Ref: NCT01417026. For more details, please see Intranasal Oxytocin and Learning in Autism(Open in new window) 

• The University of California, San Francisco is running a study to 1) To investigate the role of the affiliative neuropeptide oxytocin in unhealthy interactions in families of patients with schizophrenia and families of patients with autism spectrum disorder, and 2) to investigate whether manipulation of this oxytocinergic system positively influences these family interactions. Clinical Trials Gov Ref: NCT02302209.  For more details, please see Dyad Oxytocin Study (DOS) Full Item(Open in New Window)

• The University of North Carolina, Chapel Hill is running a trial to to evaluate oxytocin as a supplemental treatment for improving social difficulties in individuals with autism. Clinical Trials Gov Ref: NCT01308749. For more details, please see A Study of Oxytocin in Children and Adolescents With Autistic Disorder(Open in new window)

Updated

17 Jun 2022

Last Review

01 Nov 2017

Next Review

01 May 2024